Screenings for the genetic disorder alpha, antitrypsin deficiency (AAT Defi
ciency) have been one of two models: large screenings of general population
s and small targeted detection programs in high-risk groups. The most appro
priate screening and detection methodologies in terms of target populations
, subject participation and yield of positive tests, however, have not been
well defined. The major objective of this pilot study was to evaluate the
effectiveness in terms of participation of two different AAT Deficiency det
ection programs using a self-administered fingerstick blood test. Individua
ls ages 30-60 under the care of a pulmonary physician and with a diagnosis
of emphysema, COPD, chronic bronchitis, or bronchiectasis were the targeted
population. Participants were offered AAT Deficiency testing in the pulmon
ary physician's office compared with testing offered through mail. Particip
ation (i.e., frequency of subject participation in the detection program) o
f two different AAT Deficiency detection programs. Non-participation. was d
ue to fear of self-administered testing and research studies; women were mo
re likely to participate than men. Eligible subjects were significantly mor
e likely to participate when offered testing by their pulmonary physician i
n-office (83%) than mail-only (42%) (P < 0.02). Although self-administered
genetic testing is available, highest participation in AAT Deficiency detec
tion program was found when offered directly by the physician. This finding
may have implications for screening and detection of other genetic disease
s. Future studies need to evaluate the yield (i.e., frequency of positive t
ests) of these detection methodologies in highly targeted populations. (C)
2001 Wiley-Liss, Inc.